ACTRN12612000313831已完成3 期
Tranexamic acid for prevention of postpartum hemorrhage in women undergoing elective cesarean section
Faculty of Medicine,Assiut University0 个研究点目标入组 700 人开始时间: 2012年3月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 19 Years 至 49 Years（—）
- 性别
- Female
入选标准
- •All pregnant women with single fetus planned to have elective cesarean section at greater than 36wks gestation
排除标准
- •1. History of medical disorders.
- •2. Preclampsia.
- •3. Antepartum hemorrhage.
- •3. History of thromboembolic disorders.
- •4. Polyhydramnios.
- •5. Macrosomia.
- •6. History of sensitivity to Tranexamic acid.
- •7. Patients taking anticoagulant therapy.
研究者
相似试验
进行中（未招募）
1 期
impact de l'injection d'acide tranexamique en prévention de l'hémorragie du post partum après un accouchement par voie bassepostpartum hemorrhageEUCTR2014-001748-39-FRCHU d'Angers
进行中（未招募）
1 期
TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean DeliveryEUCTR2017-001144-36-FRCHU de Bordeaux4,524
招募中
3 期
World Maternal Antifibrinolytic Trial-2PACTR201909735842379ondon School of Hygiene and Tropical Medicine10,000
已完成
不适用
WORLD MATERNAL ANTIFIBRINOLYTIC TRIACirculatory SystemPregnancy and ChildbirthPostpartum haemorrhagePACTR201007000192283ondon School of Hygiene and Tropical Medicine
进行中（未招募）
1 期
Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind, placebo controlled trial - WOMAN: The World Maternal Antifibrinolytic Trial (Version 1)Postpartum haemorrhageMedDRA version: 13.1 Level: LLT Classification code 10036417 Term: Post-partum haemorrhageEUCTR2008-008441-38-GBondon School Of Hygiene and Tropical Medicine20,060